the Effectiveness of AI Molar Mind for Smoking Cessation Through Dental Health Evaluation

February 19, 2026 updated by: Alshaimaa Ahmed shabaan, Fayoum University

the Effectiveness of AI Molar Mind for Smoking Cessation Through Dental Health Evaluation: Randomized Control Trial

Smoking cessation remains a significant public health challenge, with millions of individuals struggling to quit despite available interventions.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Oral health deterioration is a well-documented consequence of smoking, including periodontal disease, tooth discoloration, and oral cancer. Recent advancements in artificial intelligence (AI) have led to the development of AI Molar Mind, a digital tool designed to assess oral health and provide personalized feedback to motivate behavioral change. This study aims to evaluate the efficacy of AI Molar Mind in aiding smoking cessation by leveraging oral health evaluations as a motivational tool.

Study Type

Interventional

Enrollment (Estimated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Egypt
    • Alexandria Governorate
      • Fayoum, Alexandria Governorate, Egypt, 21523
        • Recruiting
        • Faculty of dentistry, Fayoum University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults aged 18-65 years
  • smoke ≥5 cigarettes per day
  • motivated to quit smoking,
  • have access to a smartphone or computer

Exclusion Criteria:

  • Pregnant women
  • individuals with severe psychiatric conditions
  • those already using other smoking cessation therapies.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: AI Molar Mind Group
Participants receive a baseline oral health assessment using AI Molar Mind
Other: AI Molar Mind
a baseline oral health assessment using AI Molar Mind, which analyzes intraoral images and self-reported oral health data.
No Intervention: Control group
Participants receive standard smoking cessation care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
smoking cessation indicator
Time Frame: base line, 6-month post smoking cessation
Biochemically verified smoking cessation at 6 months (measured by exhaled carbon monoxide levels <6 ppm).
base line, 6-month post smoking cessation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Fayoum University

Investigators

  • Principal Investigator: Alshaimaa Mohamed, PhD, Fayoum University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 12, 2026

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

January 1, 2025

First Submitted That Met QC Criteria

January 1, 2025

First Posted (Actual)

January 7, 2025

Study Record Updates

Last Update Posted (Actual)

February 20, 2026

Last Update Submitted That Met QC Criteria

February 19, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Oral health assessment AI

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe